✦ LIBER ✦

Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group

✍ Scribed by H. Curé; I. Krakowski; A. Adenis; N. Tubiana; P. Kerbrat; H. Roché; ✠B. Chevallier; M.A. Lentz; P. Fumoleau; P. Chollet

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase II trial with cystemu

✍ V. Urosevic; Ph. Chollet; A. Adenis; J. Chauvergne; P. Fargeot; H. Roche; P. Ker 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Phase II study of 1,2,4-triglycidyl uras

✍ Rouëssé, J.G.; van Oosterom, A.T.; Capellaere, P.; Kerbrat, P.; van Coninge, C.J 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 204 KB

Phase II Study of ET-743 in Advanced Sof

✍ Le Cesne, A. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

Use of c-KIT/PDGFRA mutational analysis

✍ M. Debiec-Rychter; H. Dumez; I. Judson; B. Wasag; J. Verweij; M. Brown; S. Dimit 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Results of a phase II trial with second-line cystemustine at 60&#xa0;mg/m2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group